The healthcare system is accelerating toward a value-based system, but several barriers remain in the way for providers, payers and stakeholders in between.

Penn Medicine recently launched its initiative to “transform” EHRs by making them smarter, streamlined and more interactive—with the ultimate goal of easing the work of clinicians, expediting care and creating the best patient outcomes.

Fewer than one-third of Chinese patients with acute coronary syndromes (ACS) receive guidance to participate in cardiac rehabilitation, according to research presented Oct. 11 at the Great Wall International Congress of Cardiology.

The American Hospital Association voiced its support for a $100 million telehealth pilot by the Federal Communications Commission (FCC) in written comments.

Preliminary results from the RETAKO trial, a study of takotsubo syndrome (TTS) in the Spanish population, have identified cardiogenic shock as an independent, strong predictor of mortality and complexities in TTS patients—a demographic that’s already at considerable risk for complications.

People with unrecognized myocardial infarction carry a lower short-term risk of death but an equal 10-year risk of mortality compared to those with clinically diagnosed heart attacks, according to an analysis of the ICELAND MI study published in JAMA Cardiology.

Overnight attending radiologist coverage leads to reduced turnaround times, higher satisfaction among referring clinicians and increased educational value for residents, according to new research published in Current Problems in Diagnostic Radiology.

Three additional Aetna directors will join CVS Health’s board of directors following completion of the $69 billion merger between the two companies.

Deep learning may accurately identify false-positive mammograms and distinguish such from images identified as malignant or negative, according to new research published Oct. 11 in the journal Clinical Cancer Research.

Researchers at the University of California, Los Angeles (UCLA) School of Medicine and School of Dentistry have been awarded a five-year, $5 million grant from the National Cancer Institute to develop liquid biopsy tools as a method for lung cancer screening.